Shares of drugmaker Cipla are expected to be in focus on Monday as the company's promoters could sell up to 1.72% stake in the company via block deals. The company may set the offer price at Rs 1,442 per share according to a report that has estimated the block size at Rs 2,000 crore.

The news was reported by CNBC TV18 citing sources and approximately 1.39 crore shares could be on the block. 

At this offer price, the shares will be off-loaded at a 6% discount over Friday's closing price of Rs 1,532. Today, Cipla shares settled higher by Rs 39.25 or 2.63% over the Thursday closing price.

The promoters of Cipla had in May this year sold a 2.53% stake for Rs 2,751 crore in a block deal on the NSE. According to the NSE block deal data, Shirin Hamied, wife of MK Hamied, vice-chair and non-executive director on the Cipla board and her daughters Rumana Hamied, Samina Hamied, and Okasa Pharma Private Ltd, all categorized as promoter group, had then sold 2.04 crore shares at Rs 1,345 apiece.

The company in a stock exchange release said the stake sale was intended at raising funds for specific needs, including philanthropy.

The Drug posted 15% growth in its consolidated net profit to Rs 1,303 crore for the quarter that ended September 2024, compared with Rs 1,131 crore in the year-ago period. The profit was above the ET Now poll estimates of Rs 1,218 crore.

Revenue from operations rose 6% year-on-year to Rs 7,051 crore in the July-September 2024 period as against Rs 6,678 crore in the last year period.

Published on Dec 02, 2024, 08:27:16 AM IST

Vikasdhan - Grow your Dhan with Vikasdhan 

Disclaimer- not an investment advice, only for educational purpose. To read complete disclaimer, click on the link https://www.vikasdhan.com/disclaimer